Newton Charles W.

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -22% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -6%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Newton Charles W.'s trades of Keros Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
373.04
Quantity 77,787 -34.3%
Value US$3,178,203
Transaction date
Proposed sale
Price
384.98
Quantity 52,533
Value US$3,614,495
Transaction date
Proposed sale
Price
9.95
Quantity 550
Value US$5,472
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-20 2026-08-18
PlS Planned sale
77,787 -34.3%
373.04
US$3,178,203 		77,787 -34.3% 373.04 US$3,178,203
2026-08-18 2026-08-18
PrS Proposed sale
52,533
384.98
US$3,614,495 		52,533 384.98 US$3,614,495
2026-06-15 2026-06-11
PlS Planned sale
9,658 +8.4%
175.64
US$3,719,933 		9,658 +8.4% 175.64 US$3,719,933
2026-06-11 2026-06-11
PrS Proposed sale
550
9.95
US$5,472 		550 9.95 US$5,472
2025-08-22 2025-08-21
S Sale
1,453 -8.7%
10.54
US$15,320 		1,453 -8.7% 10.54 US$15,320
2025-08-13 2025-08-12
S Sale
136 -1.5%
10.34
US$1,406 		136 -1.5% 10.34 US$1,406
2025-08-13 2025-08-11
PlS Planned sale
131 -1.5%
10.53
US$1,379 		131 -1.5% 10.53 US$1,379
2025-03-18 2025-03-17
B Purchase
200,000 +inf%
0.56
US$111,620 		200,000 +inf% 0.56 US$111,620